A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
Trial details
- Registry ID
- NCT06007690
- Drugs studied
- Bel-sar, Infrared Laser, Sham Infrared Laser, Sham Microinjector and 1 more